Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ClearPoint Neuro (CLPT)
NASDAQ:CLPT
Holding CLPT?
Track your performance easily
CLPT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.11 - $14.13
Previous Close$10.96
Volume33.87K
Average Volume (3M)209.36K
Market Cap
$305.92M
Enterprise Value$284.70M
Total Cash (Recent Filing)$21.60M
Total Debt (Recent Filing)$3.69M
Price to Earnings (P/E)―
Beta1.83
Next Earnings
Feb 26, 2025EPS Estimate
-$0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.69
Shares Outstanding27,584,699
10 Day Avg. Volume315,516
30 Day Avg. Volume209,356
Standard Deviation0.21
R-Squared0.08
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)10.44
Price to Sales (P/S)9.94
Price to Cash Flow (P/CF)-63.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue9.36
Enterprise Value/Gross Profit20.91
Enterprise Value/Ebitda-16.12
Forecast
1Y Price Target
$16.33Price Target Upside47.38% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
ClearPoint Neuro News
PremiumCompany Announcements
ClearPoint Neuro Achieves Record Q3 Revenue Growth
PremiumCompany Announcements
ClearPoint Neuro Achieves Strong Q3 Growth and Debt RepaymentOwnership Overview
10.10% Insiders
6.64% Mutual Funds
9.15% Other Institutional Investors
69.53% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CLPT FAQ
What was ClearPoint Neuro’s price range in the past 12 months?
ClearPoint Neuro lowest stock price was $5.11 and its highest was $14.13 in the past 12 months.
What is ClearPoint Neuro’s market cap?
Currently, no data Available
When is ClearPoint Neuro’s upcoming earnings report date?
ClearPoint Neuro’s upcoming earnings report date is Feb 26, 2025 which is in 97 days.
How were ClearPoint Neuro’s earnings last quarter?
ClearPoint Neuro released its earnings results on Nov 07, 2024. The company reported -$0.18 earnings per share for the quarter, missing the consensus estimate of -$0.173 by -$0.007.
Is ClearPoint Neuro overvalued?
According to Wall Street analysts ClearPoint Neuro’s price is currently Undervalued.
Does ClearPoint Neuro pay dividends?
ClearPoint Neuro does not currently pay dividends.
What is ClearPoint Neuro’s EPS estimate?
ClearPoint Neuro’s EPS estimate is -$0.16.
How many shares outstanding does ClearPoint Neuro have?
ClearPoint Neuro has 27,584,700 shares outstanding.
What happened to ClearPoint Neuro’s price movement after its last earnings report?
ClearPoint Neuro reported an EPS of -$0.18 in its last earnings report, missing expectations of -$0.173. Following the earnings report the stock price went down -13.189%.
Which hedge fund is a major shareholder of ClearPoint Neuro?
Among the largest hedge funds holding ClearPoint Neuro’s share is Royce & Associates LLC. It holds ClearPoint Neuro’s shares valued at N/A.
---
ClearPoint Neuro Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$16.33 (47.38% Upside)
$16.33 (47.38% Upside)
Blogger Sentiment
Bullish
CLPT Sentiment 66%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 29.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 4.0%
Last 30 Days ▼ 0.4%
Last 30 Days ▼ 0.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
88.15%
12-Months-Change
Fundamentals
Return on Equity
-68.36%
Trailing 12-Months
Asset Growth
-8.31%
Trailing 12-Months
Company Description
ClearPoint Neuro
Clearpoint Neuro, Inc. engages in the development and commercialization of innovative platforms for performing minimally invasive surgical procedures in the brain and heart. It conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform is comprises of ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Irvine, CA.
---
CLPT Company Deck
---
CLPT Earnings Call
Q3 2024
0:00 / 0:00
---
CLPT Stock 12 Month Forecast
Average Price Target
$16.33
▲(47.38% Upside)
Technical Analysis
Best Analysts Covering CLPT
1 Year
1 Year Success Rate
8/13 ratings generated profit
1 Year Average Return
+35.27%
reiterated a buy rating 8 days ago
Copying Frank Takkinen's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +35.27% per trade.
---